New pill could clear psoriasis in thousands

NCT ID NCT07432854

Not yet recruiting Disease control Sponsor: Dermavon Holdings Limited Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an experimental tablet called CMS-D001 for adults with moderate to severe plaque psoriasis. About 540 participants will receive either the drug or a placebo to see if it improves skin symptoms like redness, scaling, and thickness. The goal is to measure how many people achieve at least 75% clearer skin after treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

psoriasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MODERATE TO SEVERE PLAQUE PSORIASIS

Contacts and locations

Locations

Affiliated Hospital of Chengde Medical College

Chengde, Hebei, China
Affiliated Hospital of Hebei University of Engineering

Handan, Hebei, China
Beijing Tongren Hospital Affiliated to Capital Medical University

Beijing, China
Hangzhou First People's Hospital

Hangzhou, Zhejiang, China
Hangzhou Third People's Hospital

Hangzhou, Zhejiang, China
Henan Provincial People's Hospital

Zhengzhou, Henan, China
Jining First People's Hospital

Jining, Shandong, China
Nanyang Central Hospital

Nanyang, Henan, China
Sanmenxia Central Hospital

Sanmenxia, Henan, China
Shandong First Medical University Affiliated Dermatology Hospital

Jinan, Shangdong, China
Shanghai Dermatology Hospital

Shanghai, China
Shijiazhuang Traditional Chinese Medicine Hospital

Shijiazhuang, Hebei, China
Southern Medical University Dermatology Hospital

Guangzhou, Guangdong, China
The First Affiliated Hospital of Bengbu Medical College

Bengbu, Anhui, China
The First Affiliated Hospital of Wannan Medical College (Yijishan)

Wuhu, Anhui, China
The First Hospital of Jilin University

Changchun, Jilin, China
The Fourth Affiliated Hospital of Hebei Medical University

Shijiazhuang, Hebei, China
The Second Affiliated Hospital of Harbin Medical University

Harbin, Heilongjiang, China
Wuxi Second People's Hospital

Wuxi, Jiangsu, China
Zhejiang Provincial People's Hospital

Hangzhou, Zhejiang, China
Zhujiang Hospital of Southern Medical University

Guangzhou, Guangdong, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.